Study ID: BFS-AS-306 | 2013-000081-11
Study Title
- Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAXֲ® Inhalation Powder Versus SYMBICORTֲ® TURBOHALERֲ®
Teva Identifier
- BFS-AS-306 | 2013-000081-11
ClinicalTrials.gov Identifier
- NCT01803555
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Budesonide/Formoterol SPIROMAXֲ® | Drug: SYMBICORTֲ® TURBOHALERֲ®
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- 06/01/2013 - 07/01/2014
Phase
- Phase 3
Study Type
Interventional